Healthequity Inc

Healthequity Inc(HQY)股票分析

$96.370

+3.074 (+3.19%)收盤時

Loading chart…
High
97.990
Open
93.620
VWAP
95.71
Vol
2.26M
Mkt Cap
7.33B
Low
92.770
Amount
216.26M
EV/EBITDA, TTM
12.41

HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.

AI analysis of Healthequity Inc (HQY)

buy

HealthEquity Inc is a good buy right now due to its strong revenue growth and profitability indicators. The company reported a 7% year-over-year revenue increase in Q1, with net income reaching $69.4 million, and a gross margin of 66.05% in Q2. However, the main risk is the recent insider selling trend, which has increased by 213.73% over the last quarter, indicating potential concerns among insiders about the stock's future performance.

Analyst Ratings (10)

+21.50% upside
Buy
9 Buy
1 Hold
0 Sell
Current: 96.37
最低
89.00
平均
117.09
最高
129.00

BTIG

2026-07-24

目標價

$115

Buy

Citizens

2026-06-01

目標價

$111

Outperform

RBC Capital

2026-05-29

目標價

$108

Outperform

BofA

2026-05-29

目標價

$125

Buy

BMO Capital

2026-04-09

目標價

$105

Outperform

估值指標

The current forward P/E ratio for Healthequity Inc (HQY) is 22.42, compared to its 5-year average forward P/E of 30.00.

Forward P/E

Fair
5Y Average P/E
30.00
Current P/E
22.42
高估
38.79
低估
21.21

Forward EV/EBITDA

Undervalued
5Y Average EV/EBITDA
17.51
Current EV/EBITDA
12.41
高估
20.36
低估
14.65

Forward P/S

Fair
5Y Average P/S
5.74
Current P/S
5.07
高估
6.48
低估
5.00

Alphio AI Price Scenarios for HQY

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%HQY

$117.84

情境價格

B

Base

Base · 50%HQY

$104.80

情境價格

B

Bear

Bear · 25%HQY

$75.96

情境價格

Whales holding HQY

G

Greenhouse Funds LLLP

+ HoldingHQY

+9.14%

3M Return

W

Wealthspire Advisors LLC

+ HoldingHQY

+4.16%

3M Return

事件時間軸

2026-08-27 (ET)

16:30:00

Nvidia's Quarterly Report Drives Tech Stocks Higher

12:30:00

Nasdaq Rises 350.95 Points on Nvidia Earnings

12:30:00

HealthEquity Shares Drop 12.6% to $91.31

10:30:00

HealthEquity Shares Drop 14.1% to $89.74

08:30:00

Company Raises FY27 Revenue Outlook to $1.411B-$1.421B

資訊

HQY FAQ — answered by Alphio AI

HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking. It operates in the Technology sector (SERVICES-BUSINESS SERVICES, NEC industry).

HealthEquity Inc is a good buy right now due to its strong revenue growth and profitability indicators. The company reported a 7% year-over-year revenue increase in Q1, with net income reaching $69.4 million, and a gross margin of 66.05% in Q2. However, the main risk is the recent insider selling trend, which has increased by 213.73% over the last quarter, indicating potential concerns among insiders about the stock's future performance.

10 analysts cover HQY: 9 rate it Buy, 1 Hold and 0 Sell. The average price target is 117.09.

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

免費開始